Star Combo Pharma Limited

ASX:S66 Stok Raporu

Piyasa değeri: AU$20.3m

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Star Combo Pharma Yönetim

Yönetim kriter kontrolleri 3/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Su Zhang

İcra Kurulu Başkanı

AU$209.7k

Toplam tazminat

CEO maaş yüzdesi90.1%
CEO görev süresi6.8yrs
CEO sahipliği8.5%
Yönetim ortalama görev süresiVeri yok
Yönetim Kurulu ortalama görev süresi6.7yrs

Son yönetim güncellemeleri

Should Shareholders Have Second Thoughts About A Pay Rise For Star Combo Pharma Limited's (ASX:S66) CEO This Year?

Nov 21
Should Shareholders Have Second Thoughts About A Pay Rise For Star Combo Pharma Limited's (ASX:S66) CEO This Year?

Recent updates

Star Combo Pharma Limited's (ASX:S66) 30% Share Price Surge Not Quite Adding Up

Aug 23
Star Combo Pharma Limited's (ASX:S66) 30% Share Price Surge Not Quite Adding Up

Star Combo Pharma (ASX:S66) Might Have The Makings Of A Multi-Bagger

Aug 13
Star Combo Pharma (ASX:S66) Might Have The Makings Of A Multi-Bagger

Star Combo Pharma Limited's (ASX:S66) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Jun 12
Star Combo Pharma Limited's (ASX:S66) 27% Dip Still Leaving Some Shareholders Feeling Restless Over Its P/SRatio

Star Combo Pharma (ASX:S66) Is Doing The Right Things To Multiply Its Share Price

May 12
Star Combo Pharma (ASX:S66) Is Doing The Right Things To Multiply Its Share Price

Star Combo Pharma Limited's (ASX:S66) Shares May Have Run Too Fast Too Soon

Mar 20
Star Combo Pharma Limited's (ASX:S66) Shares May Have Run Too Fast Too Soon

Should Shareholders Have Second Thoughts About A Pay Rise For Star Combo Pharma Limited's (ASX:S66) CEO This Year?

Nov 21
Should Shareholders Have Second Thoughts About A Pay Rise For Star Combo Pharma Limited's (ASX:S66) CEO This Year?

Star Combo Pharma's (ASX:S66) Robust Earnings Might Be Weaker Than You Think

Mar 02
Star Combo Pharma's (ASX:S66) Robust Earnings Might Be Weaker Than You Think

Rock star Growth Puts Star Combo Pharma (ASX:S66) In A Position To Use Debt

Dec 24
Rock star Growth Puts Star Combo Pharma (ASX:S66) In A Position To Use Debt

CEO Tazminat Analizi

Su Zhang'un ücretlendirmesi Star Combo Pharma'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024AU$210kAU$189k

AU$747k

Mar 31 2024n/an/a

AU$616k

Dec 31 2023n/an/a

AU$485k

Sep 30 2023n/an/a

-AU$2m

Jun 30 2023AU$196kAU$170k

-AU$4m

Mar 31 2023n/an/a

-AU$5m

Dec 31 2022n/an/a

-AU$5m

Sep 30 2022n/an/a

-AU$3m

Jun 30 2022AU$194kAU$172k

-AU$696k

Mar 31 2022n/an/a

-AU$5m

Dec 31 2021n/an/a

-AU$8m

Sep 30 2021n/an/a

-AU$8m

Jun 30 2021AU$182kAU$163k

-AU$8m

Mar 31 2021n/an/a

-AU$3m

Dec 31 2020n/an/a

AU$1m

Sep 30 2020n/an/a

AU$533k

Jun 30 2020AU$169kAU$153k

-AU$349k

Mar 31 2020n/an/a

-AU$990k

Dec 31 2019n/an/a

-AU$2m

Sep 30 2019n/an/a

-AU$2m

Jun 30 2019AU$164kAU$150k

-AU$2m

Mar 31 2019n/an/a

-AU$2m

Dec 31 2018n/an/a

-AU$3m

Sep 30 2018n/an/a

-AU$2m

Jun 30 2018AU$93kAU$85k

-AU$2m

Tazminat ve Piyasa: Su 'nin toplam tazminatı ($USD 144.48K ), Australian pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 313.13K ).

Tazminat ve Kazançlar: Su 'in tazminatı, şirketin son bir yıldaki performansıyla tutarlıydı.


CEO

Su Zhang

6.8yrs

Görev süresi

AU$209,701

Tazminat

Ms. Su Zhang, MBA, GradCertComm, BPharm serves as Chief Executive Officer at Star Combo Pharma Ltd since November 2018 and serves as its Executive Director since 2018. She served as Director at Star Combo...


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Su Zhang
CEO & Executive Director6.8yrsAU$209.70k8.48%
A$ 1.7m
JinXing Zhang
Founder7.9yrsAU$199.83k28.25%
A$ 5.7m
Richard Allely
Independent Non-Executive Chairman6.7yrsAU$101.37kVeri yok
Wei Han
Non Executive Director4.4yrsVeri yokVeri yok
Jialong Ding
Non Executive Director4.4yrsVeri yokVeri yok

6.7yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: S66 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 6.7 yıldır).